T

TherapeuticsMD
D

TXMD

1.42000
USD
0.11
(8.40%)
Market Closed
Volume
311
EPS
-0
Div Yield
-
P/E
-4
Market Cap
16,376,053
OverviewSignalsIdeasNews
Related Instruments
    AZN
    AZN
    -1.830
    (-2.81%)
    66.385 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.76 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    101.205 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    26.16 USD
    P
    PRGO
    -0.140
    (-0.52%)
    26.800 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    514.06 USD
    More
News

Title: TherapeuticsMD

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.